<DOC>
	<DOCNO>NCT01540864</DOCNO>
	<brief_summary>The purpose study compare safety effect HPP404 versus placebo body weight overweight obese subject .</brief_summary>
	<brief_title>A Safety Efficacy Study HPP404 Weight Loss Overweight Obese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Body Mass Index ( BMI ) 30.0 39.9 kg/m2 , subject additional co morbidity ; BMI 27 39.9 kg/m2 , subject co morbidity ( i.e . dyslipidemia define high LDL ( ≥ 160 mg/dL ) high total cholesterol ( ≥ 240 mg/dL ) , subject hypertension ) Systolic blood pressure &gt; 160 mmHg and/or diastolic pressure &gt; 90 mmHg Screening Visit without treatment History use tobacco nicotinecontaining product 180 day prior Screening visit Subjects type 2 diabetes fast blood glucose concentration ≥ 126 mg/dL History appetite weight modifying surgeries/procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Overweight</keyword>
	<keyword>Body Mass Index</keyword>
</DOC>